Scientific progress is the defining feature of our age, according to Barry Werth’s Billion Dollar Molecule (Simon & Schuster, £9.99, ISBN 0 671 51057 6). He tells the story of Vertex, one of the first drug companies to move away from random screening and redesign molecules structurally. Werth tracks the growth of the drug industry in well-researched detail towards its goal: the “microbial promised land of no disease”. But the single idea he offers readers is that the enlightened but competitive world of science may be the best way to understand society … full stop.
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
A type of fibre that stimulates GLP-1 release approved for use in food
2
The world's fastest spider tops 3.5 metres per second
3
The 4 must-watch science-fiction films of the year so far
4
The weirdness of neutrinos could completely rewrite particle physics
5
What is 'SpudCell'? Arguably the greatest bioengineering feat yet
6
Babies are born with the neural foundations for maths
7
The best new science-fiction novels published in July 2026
8
We’re not the most successful human species
9
Where, when and how to watch the 2026 solar eclipse
10
We’ve uncovered a master gene that switches on human development



